(Q38170026)

English

Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study

scientific article published on 09 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

0 references

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

Daniel M. Moreira

object named as

Daniel M Moreira

1

0 references

author name string

J Curtis Nickel

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Leah Gerber

3

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Roberto L Muller

4

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Gerald L Andriole

5

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Ramiro Castro-Santamaria

6

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Stephen J Freedland

7

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

language of work or name

0 references

publication date

9 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

120

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

190-196

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Sexual factors and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Epidemiologic association between prostatitis and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Inflammation and prostate cancer: a focus on infections.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Epidemiology of inflammation and prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Effect of dutasteride on the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Prostate cancer and inflammation: the evidence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Prostatitis as a risk factor for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

21 January 2018

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

7 January 2021

based on heuristic

inferred from DOI database lookup

Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes and prostate cancer risk in the REDUCE trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

7 January 2021

based on heuristic

inferred from DOI database lookup

The correlation of extent and grade of inflammation with serum PSA levels in patients with IV prostatitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer immunology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28349

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28349

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38170026&oldid=1745419694"